-
Mashup Score: 0Program Planner - 1 year(s) ago
Program Planner One fine body�
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Program Planner - 2 year(s) ago
Program Planner One fine body�
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Program Planner - 2 year(s) ago
Program Planner One fine body�
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Program Planner - 2 year(s) ago
Program Planner One fine body�
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Program Planner - 2 year(s) ago
Program Planner One fine body�
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Program Planner - 2 year(s) ago
One fine body?
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy - 2 year(s) ago
This pooled analysis assesses whether an increased risk of serious adverse events is associated with radiation therapy given within 90 days prior to an immune checkpoint inhibitor.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
#radonc assoc w/ AEs in Pts Receiving Immunotherapy: Pooled Analysis of Trials in @FDAOncology Db [Jan 6, 2022] Anscher et al. @JAMAOnc https://t.co/ttvAlBvWJf #irAE #ImmunoOnc #radonc Pneumonitis is assoc w/ XRT w/ anti-PDL1 as seen by Liu et al #AACR20 https://t.co/VkpILtNFbu https://t.co/BZmm9JWCIK
-
-
Mashup Score: 0Program Planner - 2 year(s) ago
One fine body?
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Program Planner - 2 year(s) ago
One fine body?
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Program Planner - 3 year(s) ago
One fine body?
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
Pneumonitis incidence in Pts w/ NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. #AACR20 CT086 - VCTPL08 Session https://t.co/VkpILtOd12 #lcsm #irAE #ImmunoOnc @Syapse @US_FDA @Aurora_Cancer https://t.co/B2okjijdBv